Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Repeated dose toxicity: oral

Currently viewing:

Administrative data

Endpoint:
short-term repeated dose toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Detailed study summary and tables available (main text in japanese)
Cross-reference
Reason / purpose for cross-reference:
reference to same study

Data source

Reference
Reference Type:
publication
Title:
Unnamed
Year:
1997

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
other: Guidelines for 28-day Repeat Dose Toxicity testing of Chemicals (Japan)
Deviations:
yes
Remarks:
- recovery groups
GLP compliance:
yes
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Benzyldimethylamine
EC Number:
203-149-1
EC Name:
Benzyldimethylamine
Cas Number:
103-83-3
Molecular formula:
C9H13N
IUPAC Name:
benzyldimethylamine
Details on test material:
TS-Freetext:
Purity: 99,93 wt%

Test animals

Species:
rat
Strain:
Crj: CD(SD)
Sex:
male/female
Details on test animals or test system and environmental conditions:
no details given

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
corn oil
Details on oral exposure:
male and female rats were given the different amountsdiluted in conr oil by gavage once daily over a period of 28 days
Analytical verification of doses or concentrations:
not specified
Duration of treatment / exposure:
28 days
Frequency of treatment:
daily
Doses / concentrations
Remarks:
Doses / Concentrations:
0, 50, 100, 200, 400 mg/kg bw/day
Basis:

No. of animals per sex per dose:
5
Control animals:
yes, concurrent vehicle
Details on study design:
male and female rats were fed with 0, 50, 100, 200, 400 mg7kg bw/day over a period of 28 days,
rats dosed with 50 and 100 mg/kg bw/day were killed immediately after cessation of treatment:
groups of rats dosed with 200 and 400 mg/kg bw/day were aloud to recover for 14 days and then examined accordingly
Positive control:
not required

Examinations

Observations and examinations performed and frequency:
clinical observation once a day
mortality body weight blood examinations hematology
clinical biochemistry, urinalysis
Sacrifice and pathology:
gross pathology, organ weight.microscopic examination:
brain, liver, kidney, spleen, adrenals,ovaries, testes, thymus,
respiratory system, integumentary system, cardiovascular system, reproductive system
hematopoietic system, urinary system, digestive system
Other examinations:
no data
Statistics:
Non-parametric analysis

Results and discussion

Results of examinations

Clinical signs:
effects observed, treatment-related
Mortality:
mortality observed, treatment-related
Body weight and weight changes:
effects observed, treatment-related
Food consumption and compound intake (if feeding study):
not specified
Food efficiency:
not specified
Water consumption and compound intake (if drinking water study):
not specified
Ophthalmological findings:
not examined
Haematological findings:
no effects observed
Clinical biochemistry findings:
effects observed, treatment-related
Urinalysis findings:
no effects observed
Behaviour (functional findings):
not examined
Organ weight findings including organ / body weight ratios:
effects observed, treatment-related
Gross pathological findings:
no effects observed
Histopathological findings: non-neoplastic:
effects observed, treatment-related
Histopathological findings: neoplastic:
no effects observed
Details on results:
CLINICAL SIGNS AND MORTALITY
mortality from week 2 at 400 mg/kg bw/d: males: 4/5; females.5/5
no control animal died
gross pathological examination revealed no obvious changes
histopathological examination:
inclusion bodies in hepatocytes (m+f); degeneration of adrenal cortex (f);

clinical signs.
100, 200 and 400 mg/kg bw/day, male and females: miosis
200, 400 mg/kg bw/day, male and female:: salivation
400 mg/kg bw/day, male and female: dirty fur
400 mg/kg bw/day, females: tremor before death
recovery period: 200, 400 mg/kg bw: clinical signs diappeared

BODY WEIGHT AND WEIGHT GAIN
400 mg/kg bw/day males: significantly depressed body weight.
274 g versus 334 g in control, no further information
recovery period: 361 g versus407 g in control , no further information

CLINICAL CHEMISTRY
200 mg/kg bw/day, male: not significant increase in total cholesterol which normalized during recovery period
72 mg/dl versus 51 mg/dl in controls
recovery period 53 mg/dl versus 57 mg/dl in controls
200 mg/kg bw/day, males, recovery period:
decreased Albumin/ Globulin ratio
1.06 (p<=0.05) versus 1.18 in controls
female, 200 mg/kg bw/day: significant increase in blood glucose which normalized during recovery period
116 mg/dl (p<=0.01) versus 91 mg/dl in controls
recovery period: 126 mg/dl versus 116 mg/dl in controls


ORGAN WEIGHTS (significant changes only)
males: 200 mg/kg bw/day
significantly increased absolute spleen weight but not in relative weight:
0,63 g versus 0.51 g in controls which normaluized during rcovery period
during recovery period significant increased adernal weights
absolute. 62 mg (p>=0.01)versus 51 mg
relative: 0.016 (p<=0.05) versus 0.013
female, 200 mg/kg bw/day
significantly increased liver weights which normalized during recovery:
absolute: 7.07 g (p<=0.05) versus 5.91g in controls
relative 3.251(p<= 0.05) versus 2.939

HISTOPATHOLOGY: NON-NEOPLASTIC
suvivors showed no histopathological changes

Effect levels

Dose descriptor:
NOEL
Effect level:
50 other: mg/kg
Sex:
male/female
Basis for effect level:
other: see 'Remark'

Target system / organ toxicity

Critical effects observed:
not specified

Any other information on results incl. tables

RS-Freetext:
Mortality:
at 400 mg/kg bw 4/5 males and 5/5 females died within the treatment period. Cause of deaths could not be determined.

Clinical signs:
100 mg/kg: m+f: miosis
200 mg/kg: m+f: miosis, salivation; reversible during recovery
400 mg/kg: m+f: miosis, salivation, dirty hair
f: premortal tremors
m: reduced weight gain: ~20% after 4 weeks; partial recovery after end of treatment

Food consumption:
no effects

Hematology:
400 mg/kg: reduced white cell number (the 1 surviving male)

Clinical chemistry:
200 mg/kg: increased total cholesterol

Urinalysis:
100 mg/kg: increased urine volume (m)
200 mg/kg: increased urine volume (m+f)
400 mg/kg: increased urine volume (m)

Organ weights:
200 mg/kg: increased absolute weight (spleen, m; liver, f)
increased relative weight (liver, f)
after recovery:
increased absolute weight (adrenals, m, slight)
increased relative weight (adrenals, m, slight)
400 mg/kg: decreased absolute weight (spleen, m)

Histopathology:
Survivors: no effects
Deceased animals: inclusion bodies in hepatocytes (m+f); degeneration of adrenal cortex (f);

Applicant's summary and conclusion

Executive summary:

N,N-Dimethylbezylamine was given by gavage to male and female Crj:CD (SD) rats in doses of 0 (corn oil), 50, 100, 200, 400 mg/kg bw/day diluted in corn oil over a period of 28 days. In addition, animals of the control group and animals treated with 200 and 400 mg/kg bw/day were obseserved after termination of treatment for further 2 weeks (recovery group). Mortalities of both males and females receiving 400 mg/kg were observed from week 2. Clinical observation revealed miosis in both sexes receiving 100 mg/kg and miosis and salivation in those receiving 200 and 400 mg/kg. Body weight gain was suppressed in males receiving 400 mg/kg. Slight increases in total cholesterol were observed in males receiving 200 mg/kg. Pathological examination revealed no abnormalities attributable to the test substance treatment. The NOEL for repeat dose toxicity is considered to be 50 mg/kg/day for both sexes (MHLW 1997).